| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
32,565 |
25,458 |
$4.04M |
| 11721 |
|
880 |
826 |
$12K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
16,921 |
14,339 |
$10K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,516 |
4,944 |
$5K |
| 92015 |
Determination of refractive state |
521 |
512 |
$4K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
153 |
116 |
$2K |
| 92002 |
|
45 |
45 |
$2K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
286 |
237 |
$2K |
| V2020 |
Frames, purchases |
27 |
26 |
$616.10 |
| 11720 |
|
124 |
117 |
$588.41 |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
13 |
13 |
$584.28 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,057 |
2,972 |
$300.03 |
| 90698 |
|
214 |
204 |
$265.52 |
| 90686 |
|
827 |
811 |
$208.61 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
687 |
637 |
$75.30 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,796 |
1,753 |
$39.36 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
482 |
456 |
$23.46 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
915 |
805 |
$11.65 |
| 36416 |
|
952 |
878 |
$3.33 |
| 90677 |
|
43 |
43 |
$0.00 |
| 90620 |
|
55 |
55 |
$0.00 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
864 |
832 |
$0.00 |
| 85018 |
|
167 |
162 |
$0.00 |
| 87276 |
|
100 |
100 |
$0.00 |
| 90696 |
|
30 |
30 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
251 |
236 |
$0.00 |
| 90723 |
|
13 |
13 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
27 |
25 |
$0.00 |
| 90651 |
|
130 |
129 |
$0.00 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
14 |
14 |
$0.00 |
| 90656 |
|
60 |
60 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
32 |
28 |
$0.00 |
| 0001A |
|
14 |
14 |
$0.00 |
| 90680 |
|
15 |
12 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
12 |
12 |
$0.00 |
| 90834 |
Psychotherapy, 45 minutes with patient |
21 |
13 |
$0.00 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
991 |
969 |
$0.00 |
| 90734 |
|
140 |
139 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,603 |
1,500 |
$0.00 |
| 90648 |
|
77 |
77 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
458 |
429 |
$0.00 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
214 |
206 |
$0.00 |
| 81003 |
|
769 |
715 |
$0.00 |
| 90670 |
|
286 |
277 |
$0.00 |
| 90633 |
|
89 |
87 |
$0.00 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
499 |
498 |
$0.00 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
360 |
356 |
$0.00 |
| 83655 |
|
126 |
123 |
$0.00 |
| 90710 |
|
30 |
30 |
$0.00 |
| 87400 |
|
286 |
141 |
$0.00 |
| 87634 |
|
15 |
14 |
$0.00 |
| 90715 |
|
113 |
112 |
$0.00 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
14 |
14 |
$0.00 |
| 90685 |
|
136 |
135 |
$0.00 |
| 87275 |
|
100 |
100 |
$0.00 |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
48 |
48 |
$0.00 |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
14 |
14 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
13 |
13 |
$0.00 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
13 |
12 |
$0.00 |
| 81025 |
|
15 |
15 |
$0.00 |